Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.36 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.36 |
| ▸ | ITGAL | P20701 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CRHBP | P24387 | 2/20 | 0.32 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21660750 | 0.78 | PKM (0.38) | LMNASMN1; SMN2MAOAMAOBHTT | |
| SCHEMBL19295736 | 0.76 | ALDH1A1 (0.39) | TSHR | |
| SCHEMBL29435911 | 0.73 | ABCG2 (0.40) | ABCG2ITGB2ICAM1ITGALLMNA | |
| SCHEMBL3889220 | 0.73 | ABCG2 (0.40) | ABCG2ITGB2ICAM1ITGALLMNA | |
| SCHEMBL29450629 | 0.73 | ABCG2 (0.40) | ABCG2ITGB2ICAM1ITGALLMNA | |
| SCHEMBL21898429 | 0.71 | ACHE (0.34) | ACHE | |
| SCHEMBL7637861 | 0.69 | ALDH1A1 (0.33) | LMNASMN1; SMN2TSHR | |
| SCHEMBL22241289 | 0.69 | ABCG2 (0.44) | ABCG2ITGB2ICAM1ITGALLMNA | |
| SCHEMBL3053975 | 0.69 | ABCG2 (0.32) | ABCG2ITGB2ICAM1ITGAL | |
| SCHEMBL734304 | 0.69 | ABCG2 (0.32) | ABCG2ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 878 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6353071-B1 | DESICCATING MIXTURE OF ALUMINOXANE AND SOLVENT TO PRODUCE SOLID, MIXING WITH SOLVENT, CONTACTING SECOND MIXTURE WITH INSOLUBLIZATION AGENT TO PRODUCE ALUMINOXANE COMPOSITION, COMBINING WITH TRANSITION METAL CATALYST, POLYMERIZING OLEFIN | PHILLIPS PETROLEUM COMPANY | 2002-03-05 | — | — | US | claimed |
| US-6096915-A | Processes to produce organo-aluminoxane compositions | PALACKAL SYRIAC J (US) | 2000-08-01 | — | — | US | claimed |
| WO-2023220180-A1 | METHODS OF MANUFACTURING PYRIDAZINONE COMPOUNDS | EDGEWISE THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-3838890-B1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD (CN) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023181952-A1 | COMPOUND, POLYMER COMPOUND, COMPOSITION, AND LIGHT EMITTING DEVICE | 住友化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-3932927-B1 | METAL COMPLEX AND COMPOSITION INCLUDING SAID METAL COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2023-09-27 | — | — | EP | disclosed |
| WO-2023176304-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | 住友化学株式会社 | 2023-09-21 | — | — | WO | disclosed |
| US-20230295449-A1 | COMPOSITION AND LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230295449-A1 | COMPOSITION AND LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | UDC IRELAND LIMITED (IE) | 2023-08-29 | — | — | US | disclosed |
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | UDC IRELAND LIMITED (IE) | 2023-08-29 | — | — | US | disclosed |
| US-6096915-A | Processes to produce organo-aluminoxane compositions | PALACKAL SYRIAC J (US) | 2000-08-01 | — | — | US | disclosed |
| EP-0812860-A1 | Processes to produce organo-aluminoxane compositions | PHILLIPS PETROLEUM COMPANY (US) | 1997-12-17 | — | — | EP | disclosed |
| US-5583189-A | USING A CATALYST SYSTEM COMPRISING THE REACTION PRODUCT OF A METALLOCENE COMPOUND, A SOLID ORGANOALUMINOXY PRODUCT AND AN ORGANOMETAL COMPOUND | PHILLIPS PETROLEUM COMPANY (US) | 1996-12-10 | — | — | US | disclosed |
| US-5496781-A | OLEFIN POLYMERIZATION | PHILLIPS PETROLEUM COMPANY (US) | 1996-03-05 | — | — | US | disclosed |
| US-5480848-A | CONTAINING METALLOCENE AND REACTION PRODUCT OF ACIDIC HYDROGEN FREE ORGANIC BORANE AND ORGANOALUMINOXANE; ANTIFOULING, BROAD MOLECULAR WEIGHT DISTRIBUTION; POLYETTHYLENE | PHILLIPS PETROLEUM COMPANY (US) | 1996-01-02 | — | — | US | disclosed |
| EP-0683179-A1 | Metallocene catalyst systems, preparation, and use | PHILLIPS PETROLEUM COMPANY (US) | 1995-11-22 | — | — | EP | disclosed |
| US-5416179-A | Metallocene, isobutene | PHILLIPS PETROLEUM COMPANY (US) | 1995-05-16 | — | — | US | disclosed |
| EP-0630900-A1 | Organo-aluminoxy product and use | PHILLIPS PETROLEUM COMPANY (US) | 1994-12-28 | — | — | EP | disclosed |
| US-5354721-A | Organo-aluminoxy product and use | PHILLIPS PETROLEUM COMPANY (US) | 1994-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | PAICS, EIF4A1, ECI1 | ABCG2 1142/4885ITGB2 866/4885ICAM1 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.